Ameera Patel, CEO at TidalSense: TidalSense diagnoses lung disease in under 4 minutes

TidalSense has built a handheld device that diagnoses COPD, a common lung disease, in under four minutes. It's already used across the NHS and has drawn interest from more than 60 countries since launching last year. The Cambridge-based company just raised $19m to expand into new markets.

Ameera Patel is CEO of TidalSense. She believes what matters most to healthcare providers is a better patient experience and more efficient care.

The Scaling Europe show is presented by Deel. Check them out here: https://get.deel.com/ruynb7o4lfjk

Sponsors:

Chargebee: https://www.chargebee.com/events/beelieve/london/2026

SurrealDB: https://surrealdb.com/

Airwallex: https://www.airwallex.com/uk?utm_source=other&utm_medium=partner_referral&utm_campaign=v01_emea_multi_ib_dg_prtmk_mofu_scalingeurope

Lovable: https://lovable.dev/

Timestamps:

0:00 - Introduction
0:19 - TidalSense's $19m round and what problem it solves
1:08 - Why the standard diagnostic test hasn't changed since the 1800s
2:44 - What TidalSense has built
3:35 - TidalSense's rollout across the NHS
4:21 - The demand TidalSense has seen since launching
5:16 - Ameera's personal journey to founding TidalSense
9:48 - Inside TidalSense's $19m round and its lead investor
12:02 - TidalSense's plans to expand into the US and China
14:47 - TidalSense's biggest bottleneck right now
15:59 - What's needed for TidalSense's next raise